HIM
USNA icon

Hillsdale Investment Management’s Usana Health Sciences USNA Stock Holding History

Hillsdale Investment Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-80
Closed -$4.69K – 651
2023
Q3 		$4.69K Buy
+80
New +$5K ﹤0.01% 530
2019
Q1 		– Sell
-4,100
Closed -$483K – 689
2018
Q4 		$483K Buy
+4,100
New +$474K 0.06% 220
2016
Q1 		– Sell
-4,600
Closed -$294K – 553
2015
Q4 		$294K Buy
4,600
+1,800
+64% +$117K 0.11% 268
2015
Q3 		$188K Buy
+2,800
New +$198K 0.06% 322
2014
Q2 		– Sell
-100
Closed -$4K – 595
2014
Q1 		$4K Hold
100
– – ﹤0.01% 524
2013
Q4 		$4K Sell
100
-100
-50% -$3.83K ﹤0.01% 525
2013
Q3 		$9K Hold
200
– – ﹤0.01% 465
2013
Q2 		$7K Buy
+200
New +$6.08K ﹤0.01% 490

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Hillsdale Investment Management's USNA Position: Q4 2023 in Review

Hillsdale Investment Management sold out of Usana Health Sciences (USNA) in Q4 2023, closing a stake of 80 shares — an estimated $4.69K sold.

Hillsdale Investment Management first reported a position in USNA in Q2 2013 and held it in 8 quarters. The position peaked at $483K in Q4 2018. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2023.

  • Hillsdale Investment Management reported no remaining Usana Health Sciences position as of Q4 2023 after selling out during the quarter.
  • Hillsdale Investment Management sold 80 Usana Health Sciences shares in Q4 2023, an estimated $4.69K.
  • Hillsdale Investment Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 8 quarters.
  • Hillsdale Investment Management's Usana Health Sciences position peaked at $483K in Q4 2018.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2023.

Based on Hillsdale Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.